Ygal Haupt
- Molecular Biology top 0.5%
- Oncology top 0.1%
- Cancer Research top 0.5%
- Biotechnology top 0.1%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Moshe OrenRuth MayaSue HauptRonit Vogt SionovMichael BergerZehavit GoldbergSusan HauptSheldon Rowan
- Topics
- Cancer-related Molecular Pathways (60 papers)Ubiquitin and proteasome pathways (24 papers)Cancer Research and Treatments (20 papers)
- Cited by
- OncologyBiotechnologyCancer Research
- Journals
- NatureCellNucleic Acids Research
- Partner nations
- AustraliaIsraelUnited States
In The Last Decade
Ygal Haupt
111 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Molecular Biology 9.0k
- Oncology 7.1k
- Cancer Research 2.2k
- Biotechnology 1.5k
- Pulmonary and Respiratory Medicine 973
Countries citing papers authored by Ygal Haupt
This map shows the geographic impact of Ygal Haupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ygal Haupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ygal Haupt more than expected).
Fields of papers citing papers by Ygal Haupt
This network shows the impact of papers produced by Ygal Haupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ygal Haupt. The network helps show where Ygal Haupt may publish in the future.
Co-authorship network of co-authors of Ygal Haupt
This figure shows the co-authorship network connecting the top 25 collaborators of Ygal Haupt. A scholar is included among the top collaborators of Ygal Haupt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ygal Haupt. Ygal Haupt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 28 | |
| 3 | 51 | |
| 4 | 64 | |
| 5 | 6 | |
| 6 | 260 | |
| 7 | 10 | |
| 8 | 31 | |
| 9 | 31 | |
| 10 | 26 | |
| 11 | 52 | |
| 12 | 55 | |
| 13 | 161 | |
| 14 | 49 | |
| 15 | 5 | |
| 16 | 29 | |
| 17 | Mdm2 promotes the rapid degradation of p53breakdown → | 3694 |
| 18 | p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. | 118 |
| 19 | 243 | |
| 20 | 11 |
About Ygal Haupt
Ygal Haupt is a scholar working on Oncology, Biotechnology and Cancer Research, having authored 111 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (60 papers), Ubiquitin and proteasome pathways (24 papers) and Cancer Research and Treatments (20 papers). The work is most often cited by research in Oncology (7.1k citations), Biotechnology (1.5k citations) and Cancer Research (2.2k citations). Ygal Haupt has collaborated with scholars based in Australia, Israel and United States. Frequent co-authors include Moshe Oren, Ruth Maya, Sue Haupt, Ronit Vogt Sionov, Michael Berger, Zehavit Goldberg, Susan Haupt, Sheldon Rowan, Jerry M. Adams and Karen H. Vousden. Their work appears in journals such as Nature, Cell and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.